Neil Osheroff

33PUBLICATIONS
39CO-AUTHORS
Microbial geneticsPharmacogenomicsBiofabricationGenomicsInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|May 27, 2026
Bacterial type II topoisomerases cleave DNA in a species-specific manner.

|Jan 27, 2026
Enzyme-DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial Drugs.

Jillian F Armenia, Neil Osheroff

|Jan 10, 2026
Gyrase and Topoisomerase IV as Antibacterial Targets for Gepotidacin and Zoliflodacin: Teaching Old Enzymes New Tricks.

Neil Osheroff

|Dec 23, 2025
Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases.

Chelsea A Mann, Stephanie A Halasohoris, Annette M Gray

|Oct 09, 2025
Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and In Vitro.

Alexandria A Oviatt, Jessica A Collins, Chelsea A Mann

|Aug 06, 2025
Bacterial type II topoisomerases cleave DNA in a species-specific manner.

Ian L Morgan, Jeffrey Y Jian, Neil Osheroff

Pageof 6

Frequent Collaborators

7 joint publications

Jessica A Collins

5 joint publications

Alexandria A Oviatt

4 joint publications

Mark J Mitton-Fry

4 joint publications

Elizabeth G Gibson